MC10’s mission is to extend human capabilities by making high-performance sensors virtually invisible, conformable, and wearable.
Transformational Healthcare Portfolio
Truly disruptive innovation is happening now
Clovis is a next generation molecular oncology company, specifically moving patient and tumor specific therapies through development with companion diagnostics.
Gravie removes every obstacle between the healthcare consumer and insurance independence, enabling individuals to readily choose and buy insurance, and pay for and manage all of their healthcare expenses.
Jiff is developing a mobile, consumer-centric software platform for the healthcare industry focused on connecting patients, payors, clinicians, and industrial partners.
Sonitus Medical is committed to providing advanced hearing solutions that hearing professionals such as Otologists, ENTs, and Audiologists can use to help their patients rejoin the conversation of life.
RxAnte’s advanced analytics and decision support help health care organizations improve medication use and lower costs.
ElationEMR is committed to helping physicians deliver excellent care by providing an EMR solution for the realities of the clinical setting.
Rock Health is powering the future of the digital health ecosystem, bringing together the brightest minds in technology and medicine to build better solutions.
goBalto delivers a cloud-based collaboration platform, that standardizes how clinical studies are conducted around the world.
Therapeutic Product Portfolio
We're working with extraordinary entrepreneurs
ATI is developing a miniaturized implantable neurostimulation device to provide rapid relief to debilitating pain caused by headaches.
Anacor is a biopharmaceutical company focused on discovering, developing and commercializing small molecule therapeutics derived from its novel boron chemistry platform.
EnteroMedics is committed to the delivery of safe, effective and sustainable therapies that address the growing global health crises associated with the increased prevalence of obesity and metabolic disease.
Posit Science develops software-based therapeutic programs for cognitive decline associated with aging.
HemaQuest is developing proprietary small molecules targeting specific genes that enable the treatment of serious and life threatening hematologic disorders.
Nevro was established with the vision of providing unprecedented relief to those suffering from chronic low back pain.
VertiFlex is dedicated to the advancement of minimally invasive solutions for the treatment of lumbar spinal stenosis.
Conatus Pharmaceuticals is a specialty pharmaceutical company engaged in the development of innovative human therapeutics to treat liver disease.
Cervel Neurotech is pioneering an innovative, proprietary approach to non-invasive deep brain neuro-modulation.
NxThera is developing a minimally invasive therapeutic device for patients suffering from symptoms of benign prostate hyperplasia and cancer.
Built on a foundation of longstanding
relationships with a distinct set of talented entrepreneurs
Venture capital looks easy but it is not. It isn’t like financial and market analysis, project management, strategic consulting, executive search and playground supervision, but it can require all of these skills and more. It turns out that doing it for a while is very important. The more challenges witnessed and solutions achieved, the better we can bring wisdom and relationships to the benefit of new enterprises. Certainly each company opportunity is distinct, but company challenges can be surprisingly analogous. More important is experience with companies that have been successful. They have signed up customers, launched projects, and transitioned management teams. More than a few of Aberdare startups over the years have grown to achieve market values exceeding $1billion. And, although it’s hard, we do it because we like it. We like the people and ideas that aspire to improve healthcare, and the energy required for new enterprises to thrive.